Natural history and clinical manifestations of chronic hepatitis B virus;Historia natural y manifestaciones clínicas de la hepatitis B crónica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue SUPPL. 7, 2008, Pages 11-18

  De Moura, Miguel Carneiro ^a   Marinho, Rui ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Chronic HBV carrier state; Extrahepatic manifestations; Hepatitis B; Natural history

Indexed keywords

AMINOTRANSFERASE; VIRUS DNA;

AMINOTRANSFERASE BLOOD LEVEL; ARTHROPATHY; ASSAULT; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; GENOTYPE; HEPATITIS B; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFANCY; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; POLYARTERITIS NODOSA; REVIEW; SKIN DEFECT; VIRUS CARRIER; VIRUS MUTATION; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 75149115442     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(08)76515-7     Document Type: Article

References (73)

1. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2004 97 107 (Pubitemid 38365759)
2. R. Williams Global challenges in liver disease Hepatology 44 2006 521 526 (Pubitemid 44433707)
3. W.M. Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
4. Y.-F. Liaw, N. Leung, and R. Guan Asian-Pacific consensus statement on the management of chronic hepatitis B : an update J Gastroenterol Hepatol 18 2003 239 245 (Pubitemid 36513151)
5. R. Marinho, J. Giria, and M. De Moura Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005) World J Gastroenterol 13 2007 1522 1527 (Pubitemid 46672659)
6. S.J. Hadziyannis, and D. Vassilopous Hepatitis e antigen negative chronic hepatitis B Hepatology 34 2001 617 624
7. E.K. Manesis HBeAg-negative chronic hepatitis B: from obscurity to prominence J Hepatol 45 2006 343 346 (Pubitemid 44142119)
8. J.H. Hoofnagle Hepatitis B-Preventable and now treatable N Engl J Med 354 2006 1074 1076
9. A.S. Lock, and B. McMahon Chronic hepatitis B Hepatology 45 2007 507 539 (Pubitemid 46374607)
10. S. Pungpapong, W.R. Kim, and J.J. Poterucha Natural history of hepatitis B virus infection: an update for clinicians Mayo Clin Proc 82 2007 967 975 (Pubitemid 47206372)
11. H.J. Yim, and A.S. Lok Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005 Hepatology 43 Suppl 1 2006 S173 S181
12. W.R. Kim, J.J. Poterucha, and W.K. Kremers Outcome of liver transplantation for hepatitis B in the United States Liver Transpl 10 2004 968 974 (Pubitemid 39232749)
13. P.C. Chan, H.L. Chen, M.S. Kong, et al. Factors affecting the mortality of pediatric fulminant hepatic failure in relation to hepatitis B virus infection Gastroenterol Hepatol 20 2005 1223 1227
14. R. Montalti, B. Nardo, and P. Beltempo Liver transplantation in fulminant hepatic failure: experience with 40 adult patients over a 17-year period Transplant Proc 37 2005 1085 1087 (Pubitemid 40590798)
15. C.K. Hui, N. Leung, and S.T. Yuen Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase Hepatology 46 2007 395 401 (Pubitemid 47344774)
16. A.S.F. Lok, and C.-L. Lai Longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children Hepatology 8 1988 1130 1133
17. M. Chen, M. SÃllberg, and J. Hughes Immune tolerance split between hepatitis B virus precore and core proteins J Virol 79 2005 3016 3027 (Pubitemid 40270581)
18. C. Boni, P. Fisicaro, and C. Valdatta Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 8 2007 4215 4225 (Pubitemid 46586915)
19. C.M. Chu, and Y.F. Liaw Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis Gastroenterology 92 1987 220 225
20. B.J. McMahon, P. Holck, L. Bulkow, and M. Snowball Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus Ann Intern Med 135 2001 759 768 (Pubitemid 33051260)
21. A.S. Lok, C.L. Lai, and P.C. Wu Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection Gastroenterology 92 1987 1839 1843 (Pubitemid 17072230)
22. M.F. Yuen, H.J. Yuan, C.K. Hui, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy Gut 52 2003 416 419
23. H.I. Yang, S.N. Lu, Y.F. Liaw Taiwan Community-Based Cancer Screening Project Group Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174 (Pubitemid 34764820)
24. G. Fattovich, G. Giustina, S.W. Schalm, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis Hepatology 21 1995 77 82
25. Fattovich G, Olivari N, Pasino M, et al. Long-term outcome of chronic hepatitis B in caucasian patients: mortality after 25 years. Gut. 2007. En prensa.
26. M. Manno, C. Camma, and F. Schepis Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years Gastroenterology 127 2004 756 763 (Pubitemid 39208409)
27. Y.F. Liaw, I.S. Sheen, T.J. Chen, et al. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study Hepatology 13 1991 627 631
28. A.S. Lok, R.H. Liang, E.K. Chiu, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study Gastroenterology 100 1991 182 188
29. C.M. Chu, and Y.F. Liaw HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up Hepatology 45 2007 1187 1192
30. A.S. Lok, C.L. Lai, P.C. Wu, et al. Spontaneous hepatitis B eantigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection Gastroenterology 92 1987 1839 1843
31. M.F. Yuen, D.K. Wong, and M. Sablon HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects Hepatology 39 2004 1694 1701 (Pubitemid 38702671)
32. T.I. Huo, J.C. Wu, P.C. Lee, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis Hepatology 28 1998 231 236
33. M.R. Brunetto, F. Oliveri, and B. Coco Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study J Hepatolo 36 2002 263 270 (Pubitemid 34146434)
34. J.P. Zarski, P. Marcellin, and V. Leroy Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases J Hepatol 45 2006 355 360 (Pubitemid 44160628)
35. U.H. Iloeje, H.I. Yang, J. Su, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group Gastroenterology 130 2006 678 686
36. H. Sumi, O. Yokosuka, and N. Seki Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease Hepatology 37 2003 19 26 (Pubitemid 36042140)
37. C.L. Thio, E.C. Seaberg, R. Skolasky Jr., et al. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet 360 2002 1921 1926
38. C.J. Hoffmann, and C.L. Thio Clinical implications of HIV and hepatitis B co-infection in Asia and Africa Lancet Infect Dis 7 2007 402 409
39. Y.F. Liaw, J.J. Sung, W.C. Chow Cirrhosis Asian Lamivudine Multicentre Study Group Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531 (Pubitemid 39315319)
40. C.L. Lai, M. Rosmawati, and J. Lao Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection Gastroenterology 123 2002 1831 1838 (Pubitemid 35408307)
41. P. Marcellin, T.T. Chang, S. Lim Adefovir Dipivoxil 437 Study Group Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816 (Pubitemid 36245757)
42. C.M. Chu Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma J Gastroenterol Hepatol 15 Suppl 2000 E25 E30
43. K. Ohnishi, S. Iida, and S. Iwama The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage Cancer 49 1982 672 677 (Pubitemid 12165423)
44. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, S.N. Lu REVEAL-HBV Study Group Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73 (Pubitemid 43042691)
45. M. Van Zonneveld, P. Honkoop, and B.E. Hansen Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B Hepatology 39 2004 804 810 (Pubitemid 38337661)
46. G.A. Ostapowicz, R.J. Fontana, F.V. Schiodt, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 945 954
47. D. Samuel, R. Mulledr, and G. Alexander Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 320 1993 1842 1847 (Pubitemid 23360483)
48. Carneiro de Moura M, Gameiro R, Matos L, et al. Chronic hepatitis B in Portugal: a retrospective study of patients attenting National Health System Hospitals. 2007 [en prensa].
49. D. Schupan, and F. Stickel Markers of progression H.E. Blum K.P. Maier J. Rodes T. Sauerbruch Diagnosis of liver diseases 2004 Kluwer Lancaster 15 25
50. F. Serejo, A. Costa, and M. Carneiro de Moura Alfa interferon improves liver fibrosis in chronic hepatitis C. Clinical significance of the serum-N-terminal propeptide of Procollagen type III Dig Dis Sci 46 2001 1684 1689 (Pubitemid 32727099)
51. W.M. Rosenberg, M. Voelker, and R. Thiel Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713 (Pubitemid 39575849)
52. G. Papatheodoridis, E. Hadziyannis, E. Tsochatzis, et al. Serum apoptotic caspase activity as diagnostic marker in HBeAg-negative chronic hepatitis B virus infection Gastroenterology 132 2007 A760
53. L. Castera, J. Vergniol, and J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350 (Pubitemid 40439195)
54. J. Chang, H.H. Tan, B.S. Yew, et al. Diagnostic accuracy and clinical utility of transient elastography (Fibroscan®) in the evaluation of hepatic fibrosis in an Asian population with chronic hepatitis B Gastroenterology 132 2007 A761
55. B. Coco, F. Oliveri, and A.M. Mans Transient elastography : a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 2007 360 370 (Pubitemid 46587854)
56. R.Y. Akhtar, D.T. Dieterich, and D. Carriero Low viral load chronic hepatitis B and liver histology Gastroenterology 132 2007 A761
57. S.H. Han Extrahepatic manifestations of chronic hepatitis B Clin Liver Dis 8 2004 403 418
58. A. Mason, J. Theal, and V. Bain Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease Am J Gastroenterol 100 2005 972 976 (Pubitemid 40592391)
59. P. Cacoub, D. Saadoun, M. Bourliére, et al. Hepatitis B genotypes and extrahepatic manifestations J Hepatol 43 2005 764 770
60. J.D. Kim, and A.H. Sherker Antiviral therapy: role in the management of extrahepatic diseases Gastroenterol Clin North Am 33 2004 303 708
61. K.N. Lai, P.K. LI, S.F. Lui, et al. Membranous nephropathy related to hepatitis B virus in adults N Engl J Med 324 1991 1457 1463
62. H.S. Conjeevaram, J.H. Hoofnagle, H.A. Austin, et al. Long term outcome of hepatitis B virus related glomerulonephritis after therapy with interferon alpha Gastroenterology 109 1995 540 546
63. L. Guillevin, A. Mahr, and P. Callard Hepatitis B virus related polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients Medicine (Baltimore) 84 2005 313 322 (Pubitemid 41368484)
64. S. Onay, E. Baskin, and F. Ozçay Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine tretament in a child patient Rheumatol Int 27 2007 869 872 (Pubitemid 46906635)
65. F. Bonino, and M.R. Brunetto Chronic hepatitis B e antigen (HbeAg) negative, anti-HBe positive hepatitis B: an overview J Hepatol 39 Suppl 1 2003 160 163 (Pubitemid 37222665)
66. F. Gerner, E. Lausch, and M. Friedt Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity J Med Virol 59 1999 415 423 (Pubitemid 29523138)
67. J.L. Steinberg, W. Yeo, and S. Zhong Hepatitis B virus reactivation in patients undergoing chemotherapy for solid tumours: precore/core mutations play an important role J Med Virol 60 2000 244 255 (Pubitemid 30054277)
68. L. Xunrong, A.W. Yan, and R. Liang Hepatitis B virus (HBVC) reactivation after cytotoxic or immunosupressive therapy: pathogenesis and management Rev Med Virol 11 2001 287 299 (Pubitemid 33009970)
69. Visvanathan K, Lewin DR. Immunopathogenesis: role of innate and adaptative immune responses. En: Locarnini S, editor. The control of chronic hepatitis B: the role for chemoprevention. Sem Liver Dis. 2006;26:104-15.
70. R.P. Perrillo Acute flares in chronic hepatitis B: the natural and unatural history of an immunologically mediated liver disease Gastroenterology 120 2001 1009
71. G. Raimondo, C. Balsano, and A. Craxi Occult hepatitis B virus infection Dig Liver Dis 32 2000 822 826 (Pubitemid 32098083)
72. G.K. Lau, H.H. Yiu, D.Y. Fong, et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy Gastroenterology 125 2003 1742 1749
73. A. Marzano, F. Angeluci, and P. Andreoni Prophylaxis and treatment of hepatitis B in immunocompromised patients Dig Liver Dis 39 2007 397 408 (Pubitemid 46508732)